ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 /Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company ...

The data regarding cases of heart attack is not maintained centrally, the government informed Parliament on Tuesday. In a written reply to a question in the Rajya Sabha, Union Health Minister J P ...

In 2019, a meta-analysis suggested that the risk of coronary morbidity was 30% higher among Sjögren's patients than it was ...

Chonnam National University Hospital (Hospital Director Jung) successfully performed the first procedure in the country, ...

Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an ...

ASCVD Risk Estimator Plus and PREVENT calculator would have classified many patients as low risk 48 hours before myocardial infarction.

The autonomic nervous system (ANS) is integral to cardiovascular regulation, playing a crucial role in maintaining ...

Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables ...

A study finds target lesion failure in 1 in 5 patients with STEMI within 10 years of primary percutaneous coronary ...

Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

A man in his 50s recently underwent a health screening at the Gangbuk Samsung Hospital Comprehensive Health Screening Center in Jung-gu, Seoul, and was urgently transferred to the emergency room.